Journal article
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases
V De Re, ML Tornesello, M De Zorzi, L Caggiari, F Pezzuto, P Leone, V Racanelli, G Lauletta, S Zanussi, O Repetto, L Gragnani, FM Rossi, R Dolcetti, AL Zignego, FM Buonaguro, A Steffan
Liver International | WILEY | Published : 2021
DOI: 10.1111/liv.14667
Open access
Abstract
Background: Genetic variants of IFNL4 and PDCD1 genes have been shown to influence the spontaneous clearance of hepatitis C virus (HCV) infection. We investigated the IFNL4 rs12979860 and the PDCD1 polymorphisms in 734 HCV-positive patients, including 461 cases with liver disease of varying severity and 273 patients with lymphoproliferative disorders to determine the association of these genes with patient's outcome. Methods: Expression levels of PDCD1 mRNA encoded by haplotypes were investigated by quantitative PCR in hepatocellular carcinoma (HCC) tissue and peripheral blood mononuclear cells. Flow cytometry was used to detect PD-1 and its ligand PD-L1. Results: The frequency of IFNL4 rs12..
View full abstract